BPC-157 is not an FDA-approved drug
[1] [6] Severe deficiencies may include symptoms of reduced heart function, suppression of bone marrow, as well as more various severe neurological symptoms possibly including sensory loss, abnormal balance and reflexes, memory and consciousness impairment, smell and taste problems, depression, irritability, confusion, and psychosis
Education and professional background Tavishi holds a Masters degree in Journalism and Mass Communication and began her career reporting on public affairs for broadcast
Some of these properties reproduce the physiological actions of endogenous glucocorticosteroids, but others do not necessarily reflect any of the adrenal hormones' normal functions
Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction
Thornes Glutathione-SR takes a different engineering approach to the bioavailability problem